CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
Aiguilles et seringues | Centre d'acquisitions gouvernementales - Direction du service à la clientèle et de l'exécution des contrats · CanPursue
Opportunities
Fit is part of the trial and paid plans.ClosedContrat de gré à gré

Aiguilles et seringues

Centre d'acquisitions gouvernementales - Direction du service à la clientèle et de l'exécution des contrats2019-3205-01-01-32910Québec
Open official sourceAdd to pipeline
Published
May 7, 2019
Respond by
—
Latest amendment
None

See how this opportunity fits your company

Create a free account and describe your company. With the trial, CanPursue checks every opportunity against it and explains the fit.

Create free account

Who won similar work

Create a free account to see past contracts like this one: who won and at what price.

Create free account

Description

The source did not include a description.

Procurement

Procurement type
Contrat de gré à gré
Procurement method
direct
Category
Goods
Jurisdiction
Québec

Not stated in the notice: selection criteria, region of delivery, region of opportunity, expected contract period, end user

Requirements and qualifications

Supply arrangement
Not stated in the public notice
Security requirement
Not stated in the public notice
Trade agreements
—
Limited tendering reason
—

Classification

GSIN
—
UNSPSC
42142523 Aiguille hypodermique

Amendments

No amendments observed.

Documents

No attachments listed in the open data.

Contact

No contact listed in the open data.

Related

More from this buyer

No related records observed.

Linked contracts

  • Aiguilles et seringuesMedique$116.6K

Source

Open official source

Verify the notice and download the full solicitation on the official page.

Source
SEAO
Solicitation
2019-3205-01-01-32910
Observed
Oct 2, 2026

Never miss an amendment

Track this opportunity in your pipeline and watchlists with a free account.

Create free account